Panigrahy D
No ORCID on file
· 4 papers in corpus
· active 2002-2023
Study types
- review 1
Condition tags
- endometriosis 1
Top journals
Frequent coauthors
- Butterfield CE 2
- Kaipainen A 2
- Folkman J 2
- Chaponis DM 1
- Duensing S 1
- Fishbein A 1
- Dipak Panigrahy 1
- Freedman DA 1
- Fletcher C 1
- Chen EJ 1
review
2023
Angiogenesis, the growth of new blood vessels, plays a critical role in tissue repair and regeneration, as well as in cancer. A paradigm shift is emerging in our understanding of the resolution of inflammation as an active biochemical proce…
2021
Inflammation in the tumor microenvironment is a hallmark of cancer and is recognized as a key characteristic of carcinogens. However, the failure of resolution of inflammation in cancer is only recently being understood. Products of arachid…
2010
The chemotherapeutic agent etoposide is a topoisomerase II inhibitor widely used for cancer therapy. Low-dose oral etoposide, administered at close regular intervals, has potent anti-tumor activity in patients who are refractory to intraven…
2002
Several drugs approved for a variety of indications have been shown to exhibit antiangiogenic effects. Our study focuses on the PPARgamma ligand rosiglitazone, a compound widely used in the treatment of type 2 diabetes. We demonstrate, for …